Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Carcinoma Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01744249
What this trial is testing

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Who this might be right for
Neuroendocrine TumorsAdvanced Cancer
Grupo Espanol de Tumores Neuroendocrinos 256
Testing effectiveness (Phase 2)Ended earlyNCT01921751
What this trial is testing

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaStage III Pancreatic Cancer
Radiation Therapy Oncology Group 20
Testing effectiveness (Phase 2)UnknownNCT00275119
What this trial is testing

Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04887805
What this trial is testing

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+4 more
City of Hope Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT00691054
What this trial is testing

Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy

Who this might be right for
Pancreatic Cancer
University of Miami 20
Testing effectiveness (Phase 2)WithdrawnNCT00005591
What this trial is testing

Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Alabama at Birmingham
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT00059982
What this trial is testing

Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)WithdrawnNCT03432676
What this trial is testing

Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

Who this might be right for
ATM Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00033384
What this trial is testing

CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00075647
What this trial is testing

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT06398587
What this trial is testing

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more
OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT00031837
What this trial is testing

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Gary Morrow 400
Very early researchStudy completedNCT01821612
What this trial is testing

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Alliance for Clinical Trials in Oncology 23
Testing effectiveness (Phase 2)Temporarily pausedNCT04111172
What this trial is testing

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal AdenocarcinomaGastric Adenocarcinoma+35 more
Thomas Jefferson University 48
Early research (Phase 1)Looking for participantsNCT05372614
What this trial is testing

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+3 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00078975
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto 26
Early research (Phase 1)Study completedNCT00885066
What this trial is testing

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Centre Antoine Lacassagne 30
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Next Page